The T-box transcription factor T-bet is known to control lineage commitment and interferon-γ production by T helper 1 (Th1) CD4 lymphocytes. We report here that T-bet is essential for development of CD8 lymphocyte-dependent autoimmune diabetes (type 1 diabetes [T1D]) in the rat insulin promoter–lymphocytic choriomeningitis virus (LCMV) transgenic model for virally induced T1D. In the absence of T-bet, autoaggressive (anti-LCMV) CD8 lymphocytes were reduced in number and produced less IFN-γ, but increased IL-2 compared with controls. Further analysis showed that T-bet intrinsically controls the generation, but not apoptosis, maintenance, or secondary expansion of antiviral effector/memory CD8 lymphocytes. This observation points toward a therapeutic opportunity for the treatment of T1D and other autoimmune disorders.
Skip Nav Destination
Article navigation
19 April 2004
Article|
April 19 2004
T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes
Amy E. Juedes,
Amy E. Juedes
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Evelyn Rodrigo,
Evelyn Rodrigo
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Lisa Togher,
Lisa Togher
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Laurie H. Glimcher,
Laurie H. Glimcher
2Department of Immunology and Infectious Disease, Harvard School of Public Health and Department of Medicine, Harvard Medical School, Boston, MA 02115
Search for other works by this author on:
Matthias G. von Herrath
Matthias G. von Herrath
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Search for other works by this author on:
Amy E. Juedes
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Evelyn Rodrigo
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Lisa Togher
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Laurie H. Glimcher
2Department of Immunology and Infectious Disease, Harvard School of Public Health and Department of Medicine, Harvard Medical School, Boston, MA 02115
Matthias G. von Herrath
1Division of Developmental Immunology, La Jolla Institute for Allergy and Immunology, San Diego, CA 92121
Address correspondence to Matthias G. von Herrath, Div. of Developmental Immunology, La Jolla Institute for Allergy and Immunology, 10355 Science Center Dr., San Diego, CA 92121. Phone: (858) 558-3571; Fax: (858) 558-3579; email: [email protected]
Abbreviations used in this paper: BGV, blood glucose value; GP, glycoprotein; LCMV, lymphocytic choriomeningitis virus; RIP, rat insulin promoter; T1D, type 1 diabetes.
Received:
October 30 2003
Accepted:
March 16 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (8): 1153–1162.
Article history
Received:
October 30 2003
Accepted:
March 16 2004
Citation
Amy E. Juedes, Evelyn Rodrigo, Lisa Togher, Laurie H. Glimcher, Matthias G. von Herrath; T-bet Controls Autoaggressive CD8 Lymphocyte Responses in Type 1 Diabetes . J Exp Med 19 April 2004; 199 (8): 1153–1162. doi: https://doi.org/10.1084/jem.20031873
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement